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Consumption of long-chain n-3 poly-unsaturated fatty acids (n-3 PUFA) 
is low among certain population sub-
groups in the United States, especially 
in people living in Midwestern states 
and those who dislike fish (7,8). There-
fore, there is a need to identify accept-
able food sources of n-3 PUFA. Veg-
etable oils, such as canola and soy, 
provide some n-3 fatty acids. How-
ever, these sources are high in n-6 
fatty acids and there is concern that 
they may have detrimental side effects 
(9). Eggs enriched in n-3 PUFA can be 
produced by incorporating sources of 
these fatty acids into poultry rations 
(10,11). In acceptability studies, US 
consumers responded positively to n-3 
enriched eggs (12). However, Ameri-
cans may be reluctant to consume eggs 
as a source of n-3 PUFA because of 
their cholesterol content.
Dietary intake of n-3 PUFA is asso-
ciated with a reduced risk of primary 
cardiac arrest and sudden and non-
sudden death (1–4). The plantbased 
form of n-3 PUFA, á linolenic acid 
(LNA, 18:3n-3), may also reduce coro-
nary heart disease (5). Harris (6) sug-
gests that the effects of LNA and n6 
fatty acids on serum lipids are sim-
ilar, whereas marine n-3 PUFAs ap-
pear to raise low-density lipoprotein 
(LDL) and high-density lipoprotein 
levels and reduce serum triglycerides. 
The n-3 PUFAs may have positive ef-
fects on serum lipids. Consumption of 
a large dose (20 g/day) of n-3 PUFA 
from fish oil significantly reduced both 
serum triglycerides and total serum 
cholesterol in patients with hyperlip-
idemia (13). Oh et al (14) reported that 
persons with normal lipid levels who 
consumed 4EPA and DHA-enriched 
eggs per day reduced their serum tri-
glyceride and blood pressure levels, 
but there was no effect on total serum 
cholesterol. People with normal lipid 
levels who consumed 4 LNA-enriched 
eggs per day experienced no signif-
icant effects on either serum triglyc-
erides or total serum cholesterol (15). 
There is a need to further assess the 
role of eggs as a source of n-3 PUFA in 
the US diet. The purpose of this study 
was to evaluate the effects of the addi-
tion of LNA- and DHA-enriched eggs 
on serum lipids of people with hyper-
lipidemia who were consuming a low-
fat diet.
Methods
Twenty-five volunteers with hyper-
cholesterolemia (serum cholesterol 
>5.2 mmol/L*) were recruited from 
the community. The participants—13 
men and 12 women—ranged in age 
from 26 to 73 years. None of the vol-
unteers had been diagnosed with any 
disease (including heart disease). The 
project was approved by the Institu-
tional Review Board at the University 
of Nebraska, Lincoln. Volunteers were 
randomly assigned to 3 experimen-
tal treatments: a low fat, self selected 
diet with no eggs (no egg); a low-fat 
self-selected diet with 12 n-3 PUFA-
enriched eggs per week (omega egg); 
and a low-fat, self-selected diet with 
12 control eggs per week (control egg). 
A low-fat diet was defined as <30% of 
energy from fat and <10% of energy 
from saturated fat. A Latin square de-
sign was used so that all volunteers re-
ceived each treatment during the 38-
week study. A 2-week baseline period 
was followed by a 6-week, low-fat, 
lead-in period before the first 6-week 
diet treatment began. The order of the 
diet treatments was randomized. Six-
week, low-fat, washout periods—dur-
ing which no eggs were consumed—
were used between diet treatments.
After the baseline period, volun-
teers received nutrition counseling on 
the low-fat diet by a registered dieti-
tian once every 2 weeks. Body weight 
was also monitored at each 2-week ap-
pointment. Volunteers received de-
tailed instruction on estimating serv-
ing sizes and keeping complete food 
records. They provided 3-day food re-
cords twice during each period (weeks 
3 and 6). Week 3 food records were 
used for monitoring and week 6 re-
cords were included in the data anal-
ysis. Food records were checked for 
completeness and analyzed using the 
Food Processor Plus computer pro-
gram (ESHA version 6.0, Salem, Ore). 
Mean daily energy, fat, and choles-
terol consumption were determined 
for each period. Blood samples were 
drawn from fasting subjects twice dur-
ing each period (weeks 4 and 6) and 
serum lipid levels were determined 
immediately at a certified medical lab-
oratory (Nickols Institute, Lincoln, 
Neb) using standardized laboratory 
procedures.
The Department of Animal Science 
at the University of Nebraska, Lincoln, 
produced the eggs consumed during 
the omega-egg and control-egg treat-
ment periods. The n-3 PUFA-enriched 
eggs were produced by including flax-
seed in the poultry ration (12). The 
n-3 PUFA content of the control egg 
was 65 mg/egg and this increased to 
412 mg/egg in the n-3 PUFA-enriched 
egg. The majority of the increase in n-3 
PUFA in the enriched egg was from 
LNA, which increased from 17 mg/
egg in the control egg to 277 mg/egg 
in the n-3 PUFA-enriched egg. The 
DHA content of the n-3 PUFA-en-
riched egg also increased from 35 mg/
egg in the control egg to 114 mg/egg 
in the n-3 PUFA-enriched egg.
The mean of the 2 serum samples 
obtained from each volunteer dur-
ing each treatment period was used 
for data analysis. The general lin-
ear model procedure of SAS (version 
6, 1994, SAS Institute, Gary, NC) was 
used to compare treatment means us-
ing a repeated-measures analysis of 
variance. Statistical analyses were also 
used to identify if any treatment order-
effect was present. Mean change from 
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Table 1. Mean (±SEMa) serum lipidsb of volunteers consuming a no egg, n-3 PUFAc-enriched egg, or control egg low-fatd diet 
treatment
Serum lipids                                      No egg                 n-3 egge        Control eggf
           Nonresponders   Nonresponders    Nonresponders   Nonresponders    Nonresponders Nonresponders
          (n=23)  and responders   (n=23) and responders    (n=23) and responders
          (n=25)  (n=25)  (n=25)
Cholesterol (mmol/L)g
Total  5.92±0.07  5.90±0.07  6.00±0.06  6.06±0.07  5.92±0.07  5.97±0.07
     0.08±0.20h  0.16±0.20  0.00±0.20  0.07±0.20
LDL  3.88±0.06   3.87±0.06  4.09±0.06  4.16±0.06**  3.98±0.06  4.05±0.06**
    0.21±0.17  0.29±0.17  0.10±0.17 0.18±0.17
HDL  1.24±0.02  1.22±0.02  1.24±0.02   1.21±0.02  1.26±0.02 1.23±0.02
    0.00±0.06  0.01±0.06  0.02±0.06 0.01±0.06
Triglycerides (mmol/L)i  1.73±0.09  1.76±0.08  1.46±0.09   1.50±0.09*  1.59±0.09*  1.60±0.08
    0.27±0.25   0.26±0.23  0.14±0.25 0.16±0.23
a. SEM=standard error of the mean.
b. Mean of 2 serum samples obtained at weeks 4 and 6 of each period.
c. PUFA=polyunsaturated fatty acid.
d. Low-fat diet=< 30% of energy as fat, < 10% of energy as saturated fat.
e. 12 n-3 fatty acid-enriched eggs per week.
f. 12 standard eggs per week.
g. To convert mmol/L cholesterol to mg/dL, multiply mmol/L by 38.7. To convert mg/dL cholesterol to mmol/L, multiply mg/dL by 0.026. 
Cholesterol of 5.00 mmo1/L=193 mg/dL. LDL=low-density lipoprotein. HDL=high-density lipoprotein.
h. Difference from no egg±SEM.
i. To convert mmol/L triglyceride to mg/dL, multiply mmol/L by 88.6. To convert mg/dL triglyceride to mmol/L, multiply mg/dL by 0.0113. 
Triglyceride of 1.80 mmol/L=159 mg/dL.
* P < .05 (omega egg vs control egg).
** P < .01 (no egg vs omega egg and control egg combined).
Table 2. Dietary fat intakea (mean±SEMb) of volunteers consuming a self-selected low-fatc diet with no eggs, n-3 fatty acid-
enriched eggs or control eggs added (n=25)
Dietary fat                       Diet Treatment   
 No egg n-3 eggd Control eggb   
Total fat (% of energy) 21.5±0.64XZ 24.1±0.68 24.5±0.67
Saturated fatty acids (% of energy) 6.60±0.25y 7.30±0.26 7.86±0.26
Monounsaturated fatty acids (% of energy) 7.19±0.29XZ 8.97±0.32 9.32±0.31
Polyunsaturated fatty acids (% of energy) 5.07±0.26 5.56±0.28 4.93±0.28
n-3 Fatty acids (mg/d) 620±71X 1,420± 76Y 658±75
Cholesterol (mg/d) 142±17.8XZ 468±19.1 481±18.8
 
a. Mean of 3 days obtained at week 6 of each period.
b. SEM=standard error of the mean.
c. Low-fat diet=<30% of energy as fat, < 10% of energy as saturated fat.
d. 12 n-3 fatty acid-enriched eggs/week.
e. 12 standard eggs/week.
x. Different from n-3 egg P<.05
y. Different from control egg P<.0001
z. Different from control egg P<.05 
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no egg to either n-3 egg or standard 
egg was calculated.
Results and Discussion
Analysis of diet records indicated 
that all 25 volunteers maintained a 
low-fat diet throughout the treatment 
and washout periods. Overall mean 
daily total consumption and saturated 
fat consumption for the 36 weeks were 
22% and 7% of energy, respectively. 
Mean daily cholesterol consump-
tion was 142±18 mg/day on the no-
egg treatment and 475± 19 mg/day on 
the omega-egg and control-egg treat-
ments combined. Initial body mass 
index of the volunteers was 25.7±2.9 
(mean±SD) and results of weight mon-
itoring indicated that this did not 
change throughout the study. Anal-
ysis indicated that the order in which 
the treatments were given had no ef-
fect. Two subjects did not have blood 
samples for one treatment period. The 
statistical analysis used accounts for 
these missing data. Two volunteers 
responded to the egg treatments with 
an increase in total serum cholesterol 
that was beyond 2 standard deviations 
of the group mean. Data from these 2 
volunteers were omitted from the col-
umn labeled “Nonresponders (n=23)” 
in Table 1 but were included in the col-
umn labeled “Non responders and re-
sponders (n=25).”
There were no significant differences 
in the effects of the dietary treatments 
on any of the serum lipids in the non-
responders. However, when data from 
responders were added to the anal-
ysis, there was a significant increase 
in LDL cholesterol with the egg treat-
ments (P<.01). There was a 7% in-
crease in LDL cholesterol when omega 
eggs were added and a 5% increase 
when control eggs were added. For the 
2 responders with the high total serum 
cholesterol increase alone, correspond-
ing increases in LDL cholesterol were 
26% for omega eggs and 22% for con-
trol eggs (data not shown). Other re-
searchers have also found that there is 
a certain subset of the population that 
is responsive to dietary cholesterol and 
will therefore respond to an increase in 
dietary cholesterol with an increase in 
total and LDL serum cholesterol lev-
els (16).
The most substantial change in se-
rum lipid levels was in serum triglyc-
eride levels, which were 16% lower on 
the omega-egg diet treatment than on 
the no-egg treatment. When respond-
ers (n=25) were added to the data 
analysis, the difference in the decline 
in serum triglycerides on the 2 types 
of eggs became significant (P<.05). 
The drop in serum triglycerides from 
the no-egg treatment was 15% on the 
omega-egg treatment and 9% on the 
control-egg treatment.
Table 2 shows the effect on fat in-
take of the addition of the 12 eggs per 
week. When eggs were added to the 
low-fat diet, total fat, monounsatu-
rated fatty acids, and cholesterol sig-
nificantly increased (P<.05). Saturated 
fat intake increased significantly on 
the control-egg treatment but not on 
the omega-egg treatment. When vol-
unteers consumed the omega-egg di-
etary treatment, the intake of n-3 
PUFA more than doubled.
Applications
Results of this research indicate that 
the majority of people with hypercho-
lesterolemia who are consuming a step 
1 diet can add 12 eggs per week with-
out experiencing a significant increase 
in serum total or LDL cholesterol lev-
els. However, a subset of this popula-
tion is sensitive to dietary cholesterol 
and their serum total and LDL cho-
lesterol levels will increase with egg 
consumption.
▪ The addition of 2 n-3 PUFA enriched 
eggs per day as part of a low-fat 
diet increases the total n-3 PUFA in-
take to approximately 1.4 g/day. If 
n-3 PUFA-enriched eggs are recom-
mended as a mechanism for increas-
ing n-3 PUFA in the diet, serum cho-
lesterol must be checked to ensure 
that the patient does not respond to 
the additional dietary cholesterol. 
Dietetics professionals can monitor 
the response of their patients to the 
addition of eggs by taking a pre and 
postmeasurement of serum choles-
terol approximately 1 month apart.
▪ The n-3 enriched egg is an affordable 
food source of n-3 PUFAs that is ac-
ceptable and easy to prepare for most 
people. Three n-3 PUFA-enriched 
eggs provide approximately the same 
amount of n-3 fatty acids as one fish 
meal (equivalent to 3 oz fish). The 
number of n-3 PUFA-enriched eggs 
recommended for a person will vary 
with his or her current n-3 PUFA in-
take. It is recommended that n-3 
PUFA-enriched eggs be used as one 
source of n-3 PUFA to increase indi-
vidual consumption, particularly in 
people who seldom eat fish.
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